Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Net Cash Flow (2020 - 2024)

Immuneering has reported Net Cash Flow over the past 5 years, most recently at -$9.1 million for Q4 2024.

  • Quarterly results put Net Cash Flow at -$9.1 million for Q4 2024, down 4.94% from a year ago — trailing twelve months through Dec 2024 was -$23.3 million (down 75.81% YoY), and the annual figure for FY2025 was $92.5 million, up 497.66%.
  • Net Cash Flow for Q4 2024 was -$9.1 million at Immuneering, up from -$14.5 million in the prior quarter.
  • Over the last five years, Net Cash Flow for IMRX hit a ceiling of $56.7 million in Q3 2021 and a floor of -$36.0 million in Q3 2023.
  • Median Net Cash Flow over the past 5 years was -$5.0 million (2021), compared with a mean of $71503.9.
  • Biggest five-year swings in Net Cash Flow: surged 1723.38% in 2021 and later crashed 212.31% in 2023.
  • Immuneering's Net Cash Flow stood at $31.5 million in 2020, then crashed by 201.74% to -$32.0 million in 2021, then skyrocketed by 88.2% to -$3.8 million in 2022, then plummeted by 128.37% to -$8.6 million in 2023, then decreased by 4.94% to -$9.1 million in 2024.
  • The last three reported values for Net Cash Flow were -$9.1 million (Q4 2024), -$14.5 million (Q3 2024), and -$6.6 million (Q2 2024) per Business Quant data.